Reverse Double Switch Operation for the Borderline Left Ventricle.

Biventricular repair Borderline left heart Single ventricle

Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
30 Aug 2024
Historique:
received: 27 04 2024
revised: 02 08 2024
accepted: 21 08 2024
medline: 2 9 2024
pubmed: 2 9 2024
entrez: 1 9 2024
Statut: aheadofprint

Résumé

(s): This study investigates outcomes of the reverse double switch operation (R-DSO) and ventricular switch (VS), novel approaches for patients with D-looped borderline left hearts that utilize the morphologic right ventricle as the systemic ventricle and the hypoplastic left ventricle as the sub-pulmonary ventricle. This retrospective review analyzed early outcomes of children who underwent R-DSO/VS at a single institution between 2015 and 2023. Our primary endpoints were right ventricular (RV) function and tricuspid regurgitation (TR). Secondary outcomes included mortality, reoperation, and perioperative complications. Twenty-eight patients underwent either R-DSO (N=19) or VS (N=9). In nineteen patients, a decompressing bidirectional cavo-pulmonary shunt was utilized, creating a reverse 1.5 switch. Median age at R-DSO/VS was 3.1 years (range 9 months-12 years). At a median follow-up of 1.0 years (range 38 days-7.2 years), no mortalities or heart transplants had occurred. Mild-moderate or greater RV dysfunction was detected in four patients, and mild-moderate or worse TR was also detected in four patients. Three patients required reoperations. Preoperative RV EF < 55% was associated with higher incidence of postoperative RV dysfunction. The R-DSO/VS strategy is an alternative to single ventricle palliation or anatomic biventricular repair in the borderline left heart. Concerns for RV dysfunction and TR mandate close monitoring. Patients with preoperative RV dysfunction may be at risk for postoperative RV dysfunction. Further studies with longer follow-up are needed to delineate outcomes in comparison to the Fontan pathway and identify optimal candidates for this novel strategy.

Identifiants

pubmed: 39218145
pii: S0022-5223(24)00769-4
doi: 10.1016/j.jtcvs.2024.08.035
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Annie R Abruzzo (AR)

Harvard Medical School, Boston, MA.

Rebecca S Beroukhim (RS)

Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Sarah Campos (S)

Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Sunil Ghelani (S)

Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Christopher W Baird (CW)

Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Eric N Feins (EN)

Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Pedro J Del Nido (PJ)

Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Sitaram M Emani (SM)

Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Classifications MeSH